IPPOSI’s strategic priorities are:

  1. Build IPPOSI brand and profile as a consensus-building group that influences access to Health Innovation*
  2. Actively advocate# through our patient-led perspective for improved and equitable patient access to Health Innovation
  3. Promote meaningful patient involvement in Health Research and Policy
Over the period of 2016-2020, our work will focus on achieving the following goals:

Goal 1: Position IPPOSI as the collective voice of Patients, Science and Industry in enabling involvement in, and improving access to Health Innovation

Goal 2: Raise understanding of patient issues related to access to health innovation, with IPPOSI seen as a key player in developing solutions

Goal 3: Create a cohort of patients and patient advocates who are trained, and playing an increased role in health research and policy

Goal 4: Be leaders in influencing health reform, regulation, legislation related to the IPPOSI strategy

* Note 1: For the purposes of the IPPOSI strategy ‘Health Innovation’ is defined as new and existing Medicines, Interventions (both medical and non-medical), Medical Devices, E-Health Processes & Technologies, Information architecture/infrastructure (i.e. how information will be designed and used)

# Note 2: For the purposes of the IPPOSI strategy, advocacy is defined as the strategic use of IPPOSI representatives to increase awareness and understanding of issues related to patient access to, and involvement in health innovation across government, agency and regulatory spheres. IPPOSI advocacy activities will work in concert with other efforts carried out by patient organisations in the area of access to health innovations. Through a combination of high-level approaches, IPPOSI advocacy efforts will aim to help policy makers, individual agencies and regulators understand how an educated, empowered patient community can support each agency’s mission and business needs.

IPPOSI members were canvassed for their ideas on relevant health topics for IPPOSI to focus on over the two periods of 2017-2018 and 2019-2020. You can review their responses in the prioritisation toggle below.